ABSTRACT Background The recent approval of disease‐modifying therapies (DMTs) for early Alzheimer's disease (AD) marks a major shift in clinical practice. Biomarker confirmation of amyloid pathology is now required alongside clinical assessment, and blood‐based tests are improving accessibility.
Tim Van Langenhove +31 more
wiley +1 more source
Neurofibrillary tangles predict dementia in patients with carotid stenosis. [PDF]
Zahra S +9 more
europepmc +1 more source
<i>Ficus religiosa</i> leaf extract mitigates the neurofibrillary tangles and amyloid plaques in aluminium chloride exposed Wistar rat brain. [PDF]
Massand A, Rai R, Rai AR, Joy T.
europepmc +1 more source
White matter microstructure is differentially impacted by cerebral amyloid angiopathy, neurofibrillary tangles, and neuritic plaque co-pathology. [PDF]
Santos A +6 more
europepmc +1 more source
NDRG2 Expression Correlates with Neurofibrillary Tangles and Microglial Pathology in the Ageing Brain. [PDF]
Fadul MM +8 more
europepmc +1 more source
Increased expression of the neuroplastin 65 protein is involved in neurofibrillary tangles and amyloid beta plaques in Alzheimer's disease. [PDF]
Zheng YN +8 more
europepmc +1 more source
Neuropathological Evidence of Reduced Amyloid Beta and Neurofibrillary Tangles in Multiple Sclerosis Cortex. [PDF]
Pansieri J +8 more
europepmc +1 more source
Outcome of resveratrol and resveratrol with donepezil combination on the β-amyloid plaques and neurofibrillary tangles in Alzheimer's disease. [PDF]
Rao YL +9 more
europepmc +1 more source
Neurofibrillary tangle-rich ganglioglioma [PDF]
Ellen Gelpi +6 more
openaire +1 more source

